Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Outset Medical Inc (OM)

Outset Medical Inc (OM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Outset Medical Inc 3052 Orchard Dr San Jose CA 95134 USA

www.outsetmedical.com Employees: 310 P: 669-231-8200

Sector:

Medical

Description:

Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.

Key Statistics

Overview:

Market Capitalization, $K 66,106
Enterprise Value, $K 127,336
Shares Outstanding, K 18,312
Float, K 17,873
% Float 97.60%
Short Interest, K 2,094
Short Float 11.44%
Days to Cover 7.98
Short Volume Ratio 0.78
% of Insider Shareholders 2.40%

Financials:

Annual Sales, $ 119,480 K
Annual Net Income, $ -81,650 K
Last Quarter Sales, $ 28,870 K
Last Quarter Net Income, $ -19,490 K
EBIT, $ -66,710 K
EBITDA, $ -64,620 K

Growth:

1-Year Return -71.30%
3-Year Return -98.63%
5-Year Return -99.59%
5-Year Revenue Growth 139.25%
5-Year Earnings Growth 92.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.84 on 02/11/26
Next Earnings Date 05/06/26
Earnings Per Share ttm -6.75
EPS Growth vs. Prev Qtr -9.18%
EPS Growth vs. Prev Year 84.49%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 03/20/25

OM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.65%
Return-on-Assets % -28.64%
Profit Margin % -68.34%
Debt/Equity 0.76
Price/Sales 0.55
Price/Cash Flow N/A
Price/Book 0.50
Book Value/Share 6.99
Interest Coverage -4.80
60-Month Beta 2.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.